DRKOOP COM INC
10-Q/A, 2000-05-15
MISC HEALTH & ALLIED SERVICES, NEC
Previous: DRKOOP COM INC, 10-Q, 2000-05-15
Next: AMERICAN INFLATABLES INC, 10QSB, 2000-05-15



<PAGE>

================================================================================

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                ________________

                                  AMENDMENT 1
                                      TO
                                   FORM 10-Q

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934
     For the quarterly period ended March 31, 2000

                                       OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

                        Commission file number 000-26275

                                drkoop.com, Inc.
             (Exact name of registrant as specified in its charter)


            Delaware                                95-4697615
     (State or other jurisdiction of             (I.R.S. Employer
     incorporation or organization)           Identification Number)

                          7000 North Mopac, Suite 400
                              Austin, Texas 78731
                    (Address of principal executive offices)
                                ________________


      (512) 583-5667 (Registrant's telephone number, including area code)
                                ________________

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days

     (1)  Yes    X                            No
              --------                           --------
     (2)  Yes    X                            No
              --------                           --------

     As of April 30, 2000 there were 34,724,249 shares of the Registrant's
common stock outstanding.

================================================================================
<PAGE>

                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                            drkoop.com, Inc.


Date:  May 15, 2000                           /s/   Susan M. Georgen Saad
                                              ----------------------------------
                                              Name    Susan M. Georgen Saad
                                              Title:  Chief Financial Officer


                                      28
<PAGE>

                                 EXHIBIT INDEX

Exhibit
  No.             Description
- -------           -----------

  27              FINANCIAL DATA SCHEDULE

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONATINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM drkoop.com,
INC.'S REPORT ON FORM 10-Q FOR THE THREE MONTHS ENDED MARCH 31, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               MAR-31-1999             MAR-31-2000
<CASH>                                           2,021                  23,861
<SECURITIES>                                         0                       0
<RECEIVABLES>                                      406                   4,926
<ALLOWANCES>                                         0                    (203)
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                 2,539                  47,318
<PP&E>                                             497                  14,945
<DEPRECIATION>                                    (107)                 (2,764)
<TOTAL-ASSETS>                                  11,717                  78,205
<CURRENT-LIABILITIES>                            5,577                  17,220
<BONDS>                                              0                       0
                           29,342                       0
                                          3                       0
<COMMON>                                             9                      31
<OTHER-SE>                                     (23,213)                 47,910
<TOTAL-LIABILITY-AND-EQUITY>                    11,717                  78,205
<SALES>                                            404                   4,743
<TOTAL-REVENUES>                                   404                   4,743
<CGS>                                                0                       0
<TOTAL-COSTS>                                    2,048                  19,365
<OTHER-EXPENSES>                                 2,620                  10,215
<LOSS-PROVISION>                                     0                     225
<INTEREST-EXPENSE>                                 (31)                    305
<INCOME-PRETAX>                                (24,378)                (24,757)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (24,378)                (24,757)
<EPS-BASIC>                                         (3)                     (1)
<EPS-DILUTED>                                       (3)                     (1)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission